Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening

Table 2 Univariate and multivariate regression analyses of screening completion

	No. total	No. completing screening	OR (95% CI)	p-value^a	aOR (95% CI)	p-value
Gender
Male	255	176	Reference		Reference
Female	216	150	1.03 (0.70,1.53)	0.871	1.10 (0.72, 1.69)	0.661
Refugee status
Refugee claimant	95	42	Reference		Reference
Privately-sponsored	225	185	5.69 (3.36, 9.65)	< 0.001	2.81 (1.53, 5.15)	0.001
Government-assisted	151	99	2.40 (1.42, 4.07)	0.001	1.38 (0.76, 2.49)
Origin, by TB incidence
Low/Intermediate incidence country	278	201	Reference		Reference
High incidence country	193	125	0.69 (0.47, 1.03)	0.069	0.86 (0.55, 1.36)	0.524
Screening test
Sequential	240	129	Reference		Reference
Solo-QFT	231	197	4.84 (3.12, 7.52)	< 0.001	3.74 (2.30, 6.09)	< 0.001

No. number, OR odds ratio, CI confidence interval, aOR adjusted odds ratio, QFT quantiferon Gold Plus;
^aSignificant value defined as p ≤ 0.05; Log likelihood = − 250.43577, p-value final model = 0.000, No. of observations in final model = 467

ISSN: 1471-2334